Development of Controlled-Release Buccoadhesive Hydrophilic Matrices of Diltiazem Hydrochloride: Optimization of Bioadhesion, Dissolution, and Diffusion Parameters

ABSTRACT Buccoadhesives have long been employed to improve the bioavailability of drugs undergoing significant hepatic first-pass metabolism. Diltiazem hydrochloride (DLZ) is also reported to have low oral bioavailability due to an extensive hepatic first-pass effect. Controlled-release buccoadhesive hydrophilic matrices containing DLZ were prepared using a 32 factorial design. Amounts of Carbopol® 934P (CP) and Methocel® K100LV (HPMC) were taken as the formulation variables (factors) for optimizing bioadhesion, and kinetics of dissolution and diffusion. A mathematical model was generated for each response parameter. Bioadhesive strength tended to vary quite linearly in increasing order with increasing amount of each polymer. The drug release pattern for all the formulation combinations was found to be non-fickian, approaching zero-order kinetics. The values of permeation coefficient tended to vary non-linearly with polymer amount, depicting the plausibility of interaction between the two polymers. Suitable combinations of the two polymers provided adequate bioadhesive strength and a fairly regulated release profile up to 10 hr. The response surfaces and contour plots for each response parameter are presented for further interpretation of the results. The optimum formulations were chosen and their predicted results found to be in close agreement with experimental findings.

[1]  O. L. Davies,et al.  Design and analysis of industrial experiments , 1954 .

[2]  R. D. Hossie,et al.  Buccal Absorption of Drugs , 1971 .

[3]  C. Goldie,et al.  Optimization Techniques , 1971, Nature.

[4]  Milo Gibaldi,et al.  Drugs and the pharmaceutical sciences , 1975 .

[5]  N. Peppas,et al.  Mechanisms of solute release from porous hydrophilic polymers , 1983 .

[6]  N. Peppas,et al.  A simple equation for the description of solute release. III. Coupling of diffusion and relaxation , 1989 .

[7]  K. Goa,et al.  Diltiazem. A reappraisal of its pharmacological properties and therapeutic use. , 1990, Drugs.

[8]  N. Kettaneh-Wold,et al.  Use of experimental design in the pharmaceutical industry. , 1991, Journal of pharmaceutical and biomedical analysis.

[9]  K. Florey,et al.  Analytical profiles of drug substances and excipients , 1992 .

[10]  R. Khar,et al.  Measurement of bioadhesive strength of muco-adhesive buccal tablets: design of an in-vitro assembly , 1993 .

[11]  M. Rathbone,et al.  The oral cavity as a site for systemic drug delivery , 1994 .

[12]  Jian-Hwa Guo Bioadhesive Polymer Buccal Patches for Buprenorphine Controlled Delivery: Formulation, In-vitro Adhesion and Release Properties , 1994 .

[13]  A. Ahuja,et al.  Development Of Buccal Tablets Of Diltiazem Hydrochloride , 1995 .

[14]  J. Robinson,et al.  IN VITRO METHODS FOR MEASURING PERMEABILITY OF THE ORAL MUCOSA , 1996 .

[15]  Saranjit Singh,et al.  CORRECTION OF RAW DISSOLUTION DATA FOR LOSS OF DRUG AND VOLUME DURING SAMPLING , 1997 .

[16]  R. Khanna,et al.  Mucoadhesive Buccal Drug Delivery : A Potential Alternative To Conventional Therapy , 1998 .

[17]  Saranjit Singh,et al.  A Comprehensive Computer Program For The Study Of Drug Release Kinetics From Compressed Matrices , 1998 .

[18]  M. Gohel,et al.  Formulation design and optimization of modified-release microspheres of diclofenac sodium. , 1999, Drug development and industrial pharmacy.

[19]  O. Y. Hu,et al.  Mucoadhesive buccal disks for novel nalbuphine prodrug controlled delivery: effect of formulation variables on drug release and mucoadhesive performance. , 1999, International journal of pharmaceutics.

[20]  S. Saisivam,et al.  Design And Evaluation Of Ditiazem Hydrochloride Buccal Patches , 2000 .

[21]  H. Zia,et al.  Formulation and Optimization of a Sustained-Release Tablet of Ketorolac Tromethamine , 2002, Drug delivery.